Skip to main content

Client News

RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval

13th September 2021

Adocia To Participate in the H.C. Wainwright 23rd Annual Global Investment Conference

10th September 2021

Marinomed Biotech AG publishes clinical data on efficacy of Carragelose lozenges against respiratory viruses including SARS-CoV-2 in the International Journal of General Medicine

9th September 2021

EsoCap – unique targeted application platform to treat the upper gastrointestinal tract

9th September 2021

InflaRx to Proceed with Pivotal Development for Vilobelimab in Hidradenitis Suppurativa with New Primary Endpoint

8th September 2021

Diaccurate Acquires Clinical Stage Sole-in-Class Targeted Cancer Therapy from Merck

8th September 2021

XPhyto Reports Successful Market Launch and Growing Demand for its 25-minute COVID-19 PCR Test COVID-ID Lab

8th September 2021

RedHill Biopharma’s Opaganib Demonstrates Significant Decrease of Kidney Fibrosis

7th September 2021

Newron Receives Fourth Tranche from Financing Agreement with European Investment Bank (EIB)

6th September 2021

Avisa Diagnostics Appoints Dr. Richard Murray as Chief Medical Officer

1st September 2021